These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 8208967)
41. Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma. Fujiwaki R; Takahashi K; Kitao M Gynecol Oncol; 1997 May; 65(2):258-64. PubMed ID: 9159335 [TBL] [Abstract][Full Text] [Related]
42. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350 [TBL] [Abstract][Full Text] [Related]
43. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion. Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093 [TBL] [Abstract][Full Text] [Related]
44. Cervical carcinoma with full-thickness stromal invasion: efficacy of dynamic MR imaging in the assessment of parametrial involvement. Iwata S; Joja I; Okuno K; Miyagi Y; Sakaguchi Y; Kudo T; Hiraki Y Radiat Med; 2002; 20(5):247-55. PubMed ID: 12450104 [TBL] [Abstract][Full Text] [Related]
45. [MR imaging-evaluation of therapeutic effect of radiotherapy for uterine cervix cancer]. Kitagaki H Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Mar; 55(4):215-21. PubMed ID: 7746721 [TBL] [Abstract][Full Text] [Related]
46. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955 [TBL] [Abstract][Full Text] [Related]
47. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy. Kim BG; Kim JH; Park SY; Lee JH; Lee ED; Lee KH; Park KB; Lee BH; Kim KH Gynecol Oncol; 1996 Oct; 63(1):105-13. PubMed ID: 8898178 [TBL] [Abstract][Full Text] [Related]
48. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting? Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620 [TBL] [Abstract][Full Text] [Related]
49. Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study. Takekuma M; Hirashima Y; Ito K; Tsubamoto H; Tabata T; Arakawa A; Itani Y; Furukawa N; Murakoshi H; Takeuchi S Gynecol Oncol; 2012 Sep; 126(3):341-5. PubMed ID: 22609108 [TBL] [Abstract][Full Text] [Related]
50. Carcinoma of the cervix: value of plain and gadolinium-enhanced MR imaging in assessing degree of invasiveness. Sironi S; De Cobelli F; Scarfone G; Colombo E; Bolis G; Ferrari A; DelMaschio A Radiology; 1993 Sep; 188(3):797-801. PubMed ID: 8351350 [TBL] [Abstract][Full Text] [Related]
51. [Invasive carcinoma of the cervix uteri (stage IB-IIB): evaluation using magnetic resonance]. Sironi S; Belloni C; Taccagni L; Del Maschio A Radiol Med; 1990 Sep; 80(3):314-20. PubMed ID: 2236692 [TBL] [Abstract][Full Text] [Related]
52. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Zanetta G; Fei F; Mangioni C Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040 [TBL] [Abstract][Full Text] [Related]
53. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer. Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518 [TBL] [Abstract][Full Text] [Related]
54. Aortitis during intraarterial chemotherapy for cervical cancer. Tanaka H; Kondo E; Kawato H; Kikukawa T; Toyoda N Int J Clin Oncol; 2002 Feb; 7(1):62-5. PubMed ID: 11942052 [TBL] [Abstract][Full Text] [Related]
55. Angiographic changes in uterine cervical cancer during the course of transarterial infusion chemotherapy. Saitoh H; Nagata Y; Mitsumori M; Kokubo M; Hiraoka M Radiat Med; 1999; 17(4):305-9. PubMed ID: 10510904 [TBL] [Abstract][Full Text] [Related]